About this trial
The goal of this clinical trial is to learn if drug Pentoxifylline plus Coenzyme Q10 work to treat asthenozoospermia in subfertile male. It will also learn about the safety of drug Pentoxifylline plus Coenzyme Q10. The main questions it aims to answer are:
Does drug Pentoxifylline plus Coenzyme Q10 increase the motility of sperm in participants? What medical problems do participants have when taking drug Pentoxifylline plus Coenzyme Q10 ? Researchers will compare drug Pentoxifylline plus Coenzyme Q10 combination to Coenzyme Q10 alone to see if drug Pentoxifylline plus Coenzyme Q10 combination works better.
Participants will:
Experimental Group:Pentoxifylline 400mg twice dailyand Coenzyme Q10 100mg twice daily for 3 months.
Comparator Group: Coenzyme Q10 100mg twice daily for 3 months Visit the clinic after three months of treatment for checkups and tests
Eligibility criteria
Qualifiers
Sub fertile men with asthenozoospermia(Total motility20% to less than 42%) according to WHO semen analysis,2021.
Age 20-50 years.
Disqualifiers
Severe oligoasthenoteratozoospermia
Any medical, endocrine and genetic disorders, history of chemotherapy or radiotherapy, genital infection, genital surgery.
Antioxidants supplmentation in the last 3 months
Drug, alcohol or substance abuse, psycho-sexual abnormalities.
Trial design
Treatments tested in this trial
- Coenzyme Q 10
- Pentoxifylline 400 MG Oral Tablet
Treatment groups
Sponsors and collaborators
Mst.Sumyara Khatun
Lead sponsor
Bangladesh Medical University
Sponsor institution
Bangladesh Medical University
Collaborator